Inhibition of Platelet Functions and Thrombosis through Selective or Nonselective Inhibition of the Platelet P2 Receptors with Increasing Doses of NF449 [4,4′,4″,4″′-(Carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic Acid Octasodium Salt]

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2005-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.105.084673PMID 15792995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179.

  2006cited by this paper
• The P2 receptors in platelet function.

  2005cited by this paper
• Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.

  2005cited by this paper
• The platelet P2 receptors in thrombosis.

  2005cited by this paper
• Measurement and manipulation of [Ca2+]i in suspensions of platelets and cell cultures.

  2004cited by this paper
• Preparation of washed platelet suspensions from human and rodent blood.

  2004influential reference
• ATP Augments von Willebrand Factor-dependent Shear-induced Platelet Aggregation through Ca2+-Calmodulin and Myosin Light Chain Kinase Activation*

  2004cited by this paper
• Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.

  2004cited by this paper
• Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype.

  2003cited by this paper
• A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo

  2003influential reference
• NF449, a novel picomolar potency antagonist at human P2X1 receptors.

  2003influential reference
• Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis

  2003cited by this paper
• Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist

  2003cited by this paper
• Platelets in Thrombotic and Nonthrombotic Disorders – Pathophysiology, Pharmacology and Therapeutics

  2003cited by this paper
• Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.

  2002cited by this paper
• Platelets in Thrombotic and Non-thrombotic Disorders: Pharmacology of ticlopidine and clopidogrel

  2002cited by this paper
• Non-myeloablative allogeneic hematopoietic stem cell transplants.

  2002cited by this paper
• NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors

  2001influential reference
• Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.

  2001influential reference
• Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP

  2001cited by this paper
• P2y(12), a new platelet ADP receptor, target of clopidogrel.

  2001cited by this paper
• Intraocular pressure in genetically distinct mice: an update and strain survey

  2001cited by this paper
• Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP.

  2001cited by this paper
• ADP Receptors of Platelets and their Inhibition

  2001cited by this paper
• The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanism

  2001cited by this paper
• The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.

  2001cited by this paper
• Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

  2001cited by this paper
• Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.

  2001cited by this paper
• The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen

  2001cited by this paper
• Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications

  2000cited by this paper
• ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.

  2000influential reference
• Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors

  2000cited by this paper
• Desensitization of the Platelet Aggregation Response to ADP: Differential Down-regulation of the P2Y1 and P2cyc Receptors

  2000influential reference
• No requirement of P2X1 purinoceptors for platelet aggregation.

  1999cited by this paper
• Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice

  1999cited by this paper
• Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.

  1999influential reference
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines

  1997cited by this paper
• Rapid, highly sensitive gradient narrow-bore high-performance liquid chromatographic determination of suramin and its analogues.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

  1996cited by this paper
• Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine.

  1993cited by this paper
• Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol.

  1983cited by this paper

• Antiplatelet Therapy.

  2026cites this paper
• Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome.

  2025cites this paper
• Transfusion‐Related Acute Lung Injury: from Mechanistic Insights to Therapeutic Strategies

  2025cites this paper
• Streptococcus pyogenes Activates Human Platelets via Streptolysin S-Mediated Calcium Ion Influx

  2025cites this paper
• Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding

  2024cites this paper
• Flow cytometry identifies an early stage of platelet apoptosis produced by agonists of the P2X1 and P2X7 receptors

  2022cites this paper
• Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin‐like oxidized low‐density lipoprotein receptor‐1

  2022cites this paper
• P2X1: a unique platelet receptor with a key role in thromboinflammation

  2021cites this paper
• Plant natural products as source of new P2 receptors ligands.

  2020cites this paper
• Discovery and structure-relationships of salicylanilide derivatives as potent, non-acidic P2X1 receptor antagonists.

  2020cites this paper
• Role of Kv1.3 Channels in Platelet Functions and Thrombus Formation

  2020cites this paper
• The ATP-gated P2X1 ion channel contributes to the severity of antibody-mediated Transfusion-Related Acute Lung Injury in mice

  2019cites this paper
• Molecular determinants for agonist recognition and discrimination in P2X2 receptors

  2019cites this paper
• P2X1 receptor blockers reduce the number of circulating thrombocytes and the overall survival of urosepsis with haemolysin-producing Escherichia coli

  2019cites this paper
• Store-operated calcium entry in thrombosis and thrombo-inflammation.

  2019cites this paper
• The Platelet P2 Receptors

  2019cites this paper
• The influence of coagulation factor XIII-A V34L mutation onclot formation and stability

  2019cites this paper
• Mapping the binding site of P2X7 receptor antagonists

  2019cites this paper
• Developments in inhibiting platelet aggregation based on different design strategies.

  2019cites this paper
• P2X1 Receptors Amplify FcγRIIa-Induced Ca 2+ Increases and Functional Responses in Human Platelets

  2018cites this paper
• Evidence for shear mediated Ca 2 + entry through mechanosensitive cation

  2018cites this paper
• Advances in Antiplatelet Agents

  2017cites this paper
• Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis.

  2017cites this paper
• Evidence for shear-mediated Ca2+ entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line

  2017cites this paper
• Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation.

  2017cites this paper
• P2X1, P2X4, and P2X7 Receptor Knock Out Mice Expose Differential Outcome of Sepsis Induced by α-Haemolysin Producing Escherichia coli

  2017influential citation
• The P2 Receptors

  2017cites this paper
• Mechanosensitive and FcγRIIa-mediated Platelet Calcium Entry Mechanisms

  2017influential citation
• Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis.

  2016cites this paper
• Calcium Signalling through Ligand-Gated Ion Channels such as P2X1 Receptors in the Platelet and other Non-Excitable Cells.

  2016cites this paper
• Mechanistic insights from resolving ligand-dependent kinetics of conformational changes at ATP-gated P2X1R ion channels

  2016cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• CALL FOR PAPERS Small Vessels–Big Problems: Novel Insights into Microvascular Mechanisms of Diseases The stress of maternal separation causes misprogramming in the postnatal maturation of rat resistance arteries

  2015cites this paper
• Functional role of a polymorphism in the Pannexin1 gene in collageninduced platelet aggregation

  2015influential citation
• P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease.

  2015cites this paper
• The P2X1 Receptor Is Required for Neutrophil Extravasation during Lipopolysaccharide-Induced Lethal Endotoxemia in Mice

  2015cites this paper
• Pannexin-1 and other anion channels in platelets and megakaryocytes

  2015cites this paper
• Purinergic control of in fl ammation and thrombosis : Role of P 2 X 1 receptors

  2015cites this paper
• Use of Chimeras, Point Mutants, and Molecular Modeling to Map the Antagonist-binding Site of 4,4′,4″,4‴-(Carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic Acid (NF449) at P2X1 Receptors for ATP*

  2014cites this paper
• Endotoxemia in Mice Lipopolysaccharide-Induced Lethal Neutrophil Extravasation during Receptor Is Required for 1 The P2X

  2014cites this paper
• Amplification of human platelet activation by surface pannexin-1 channels

  2014cites this paper
• P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation

  2014cites this paper
• Etude du rôle des étapes initiales d'adhérence des plaquettes sanguines et du flux pulsatile dans l'agrégation plaquettaire

  2014cites this paper
• Purinergic control of inflammation and thrombosis: Role of P2X1 receptors

  2014influential citation
• The Molecular Basis of Antagonism at Cardiovascular P2X1 and P2X4 Receptors

  2014cites this paper
• Effect of FGFR inhibitors on chicken limb development

  2014cites this paper
• Anti-thrombotic Effects of Modified Jeho-tang using a FeCl₃-induced Carotid Arterial Thrombosis Model

  2013cites this paper
• ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMP

  2013cites this paper
• Mise au point d'outils optogénétiques pour la photorégulation de l'activité des récepteurs canaux P2X

  2013cites this paper
• Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli.

  2013cites this paper
• Effects of clopidogrel on the platelet activation response in horses.

  2013cites this paper
• P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1

  2013cites this paper
• Heat Shock Protein 90 Inhibitors Reduce Trafficking of ATP-gated P2X1 Receptors and Human Platelet Responsiveness*

  2012cites this paper
• Ligand-gated ion channels: new insights into neurological disorders and ligand recognition.

  2012cites this paper
• New perspectives in antiplatelet therapy.

  2012cites this paper
• Measuring P2X1 receptor activity in washed platelets in the absence of exogenous apyrase

  2012cites this paper
• Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop

  2012cites this paper
• The unique contribution of ion channels to platelet and megakaryocyte function

  2012cites this paper
• The impact of commercially available purinergic ligands on purinergic signalling research

  2012cites this paper
• The P2X1 receptor and platelet function

  2011cites this paper
• Identification of Human P2X1 Receptor-interacting Proteins Reveals a Role of the Cytoskeleton in Receptor Regulation*

  2011cites this paper
• P2 receptors and platelet function

  2011cites this paper
• Tissue engineering a ligamentous construct

  2011cites this paper
• Médicaments antiplaquettaires: anciennes et nouvelles thérapies

  2010cites this paper
• Antithrombotic drug therapy in cardiovascular disease

  2010cites this paper
• The P2X1 ion channel in platelet function

  2010cites this paper
• A ferric chloride induced arterial injury model used as haemostatic effect model

  2010cites this paper
• Antiplatelet medications: old and emerging therapies.

  2010cites this paper
• Platelets in Arterial Thrombosis

  2010cites this paper
• The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist.

  2009cites this paper
• Antiplatelet Therapies Targeting Thrombin Signaling Thrombin Signaling in Platelets

  2009cites this paper
• G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy

  2009cites this paper
• The thrombin receptors PAR1 and PAR4 and their relative role in platelet activation

  2009cites this paper
• The contribution of the intracellular domains to P2X1 receptor regulation

  2009cites this paper
• Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.

  2008cites this paper
• Antiplatelet drugs

  2008cites this paper
• Potential Therapeutic Targets for ATP-Gated P2X Receptor Ion Channels

  2008cites this paper
• P2 receptors, platelet function and pharmacological implications

  2008cites this paper
• CHAPTER 10 – The Platelet P2 Receptors

  2007cites this paper
• Platelet P2 receptors: old and new targets for antithrombotic drugs

  2007cites this paper
• Characterization of functional P2X(1) receptors in mouse megakaryocytes.

  2007cites this paper
• Murine Models of Vascular Thrombosis

  2007cites this paper
• Murine models of vascular thrombosis (Eitzman series).

  2007cites this paper
• Regulation of Hemostasis and Thrombosis Insights from Murine Models

  2007cites this paper
• Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.

  2007cites this paper
• Development and validation of a platelet calcium flux assay using a fluorescent imaging plate reader.

  2006cites this paper
• MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a Potent, Selective, and Stable Antagonist of the Platelet P2Y1 Receptor with Strong Antithrombotic Activity in Mice

  2006cites this paper
• ERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X1

  2006cites this paper
• Regulation of platelet functions by P2 receptors.

  2006cites this paper
• The platelet P2 receptors in arterial thrombosis.

  2006cites this paper
• ERK 2 activation in arteriolar and venular murine thrombosis : platelet receptor GPIb vs . P 2 X 1

  2006cites this paper
• P2X1 stimulation promotes thrombin receptor‐mediated platelet aggregation

  2006cites this paper
• The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.

  2005cites this paper
• The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range

  2005influential citation
• MRS2500, a potent, selective and stable antagonist of the P2Y1 receptor, with strong antithrombotic activity in mice

  2005cites this paper